ESPINOZA OCTAVIO (Chief Financial Officer) reported 1 transaction at LIGAND PHARMACEUTICALS INC
Review the transaction codes below to understand the nature of each event.
Filed: 1/6/2026ACC: 0002001011-26-000003
Officer· Chief Financial Officer
Since Mar 2026
+8.00
Net shares
Net buyer
$765.41
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
8.00 acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+8.00
Price / share
$95.68
Trade value
$765.41
% of position
0.0%
12/31/2025
28.57K→28.57K
Total
Net shares
+8.00
Net value
$765.41
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 12/31/2025 | J · J | +8.00 | $95.68 | $765.41 | 0.0% | 28.57K | 28.57K |
| Total | +8.00 | $765.41 | ||||||
Derivative Transactions0
No derivative transactions reported